- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03772119
Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
April 29, 2026 updated by: University Hospital, Tours
The treatment of child's vertebral malformations has evolved a lot including the realization of surgical vertebral resections.
The surgical techniques used are multiple, require heavy surgery, one or more approaches and surgical time, transfusions, a neurological risk (up to 20% in some series, risk of non-consolidation, insufficient correction).
These surgical techniques deserve an evaluation of the early complications and the skeletal maturity of these children (maintenance of the surgical correction, evolution of the associated curvatures).
Study Overview
Detailed Description
The treatment of child's vertebral malformations has evolved a lot including the realization of surgical vertebral resections.
The surgical techniques used are multiple, require heavy surgery, one or more approaches and surgical time, transfusions, a neurological risk (up to 20% in some series, risk of non-consolidation, insufficient correction).
These surgical techniques deserve an evaluation of the early complications and the skeletal maturity of these children (maintenance of the surgical correction, evolution of the associated curvatures).
Study Type
Observational
Enrollment (Estimated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thierry ODENT, MD-PhD
- Phone Number: +33 02 47 47 38 22
- Email: T.ODENT@chu-tours.fr
Study Locations
-
-
-
Bordeaux, France, 33000
- Recruiting
- Pediatric Surgery Service, University Hospital, Bordeaux
-
Contact:
- Yan LEFEVRE, MD-PhD
-
Grenoble, France, 38043
- Not yet recruiting
- Pediatric Surgery Service, University Hospital, Grenoble
-
Contact:
- Aurélien COURVOISIER, MD-PhD
-
Lyon, France, 69677
- Not yet recruiting
- Pediatric Surgery Service, University Hospital, Lyon
-
Contact:
- Thierry HAUMONT, MD-PhD
-
Contact:
- Vincent CUNIN, MD
-
Marseille, France, 13005
- Recruiting
- Pediatric Surgery Service, University Hospital, Marseille
-
Contact:
- Sébastien PESENTI, MD-PhD
-
Nantes, France, 44093
- Recruiting
- Pediatric Surgery Service, University Hospital, Nantes
-
Contact:
- Antoine HAMEL, MD-PhD
-
Nice, France, 06200
- Recruiting
- Pediatric Surgery Service, University Hospital, Nice
-
Contact:
- Federico SOLLA, MD
-
Paris, France, 75012
- Recruiting
- Pediatric Surgery Service, University Hospital, Armand Trousseau Hospital, AP-HP
-
Contact:
- Raphael VIALLE, MD-PhD
-
Paris, France, 75019
- Recruiting
- Pediatric Surgery Service, Robert-Debré Hospital, AP-HP
-
Contact:
- Brice ILHARREBORDE, MD-PhD
-
Contact:
- Keyvan MAZDA, MD-PhD
-
Paris, France, 75730
- Recruiting
- Pediatric Surgery Service, University Hospital, Necker Hospital, AP-HP
-
Contact:
- Lofti MILADI, MD
-
Rennes, France, 35203
- Recruiting
- Pediatric Surgery Service, University Hospital, Rennes
-
Contact:
- Philippe VIOLAS, MD-PhD
-
Saint-Etienne, France, 42055
- Recruiting
- Pediatric Surgery Service, University Hospital, Saint-Etienne
-
Contact:
- Elie HADDAD, MD
-
Contact:
- Bruno DOHIN, MD-PhD
-
Toulouse, France, 31059
- Recruiting
- Pediatric Surgery Service, University Hospital, Toulouse
-
Contact:
- Franck ACCADBLED, MD-PhD
-
Tours, France, 37044
- Recruiting
- Pediatric Surgery Service, University Hospital, Tours
-
Contact:
- Thierry ODent, MD-PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 10 years (Child)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
children from 3 to 10 years old with vertebral malformation requiring surgery for hemivertebra
Description
Inclusion Criteria:
- Child from 3 to 10 years old
- with a vertebral malformation requiring surgery for hemivertebras
Exclusion Criteria:
- Child previously operated on the spine
- Different procedure of a surgical resection of vertebral malformation
- Absence of medical follow-up
- Parents refusal concerning data storage
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Surgical treatment of hemivertebra
cohort of children with a vertebral malformation treated by surgical resection
|
Surgical resection of hemivertebra
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Immediate effectiveness of surgery: Evolution of Cobb angle
Time Frame: From baseline to 6 months after surgery
|
Effectiveness of immediate correction : spinal deformities measured by the Cobb angle on radios face and profile
|
From baseline to 6 months after surgery
|
|
Appearances of complications
Time Frame: From baseline to 6 months after surgery
|
Appearances of complications (neurological, vascular, non consolidation) at 6 months.
These complications will be gathered from hospitalization reports.
|
From baseline to 6 months after surgery
|
|
Late persistence of complications
Time Frame: From 6 months after surgery to 15 years
|
Persistent complications will be collected through clinical examination at follow-up visits.
|
From 6 months after surgery to 15 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term effectiveness of surgery: Evolution of Cobb angle
Time Frame: From 6 months after surgery to 15 years
|
Maintaining local correction with growth: spinal deformities measured by the Cobb angle on radios face and profile
|
From 6 months after surgery to 15 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Thierry ODENT, MD-PhD, University Hospttal, Tours
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2019
Primary Completion (Estimated)
February 1, 2039
Study Completion (Estimated)
February 1, 2039
Study Registration Dates
First Submitted
November 22, 2018
First Submitted That Met QC Criteria
December 7, 2018
First Posted (Actual)
December 11, 2018
Study Record Updates
Last Update Posted (Actual)
April 30, 2026
Last Update Submitted That Met QC Criteria
April 29, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- RIPH3-RNI17/HEMIVERTEBRE SOFOP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.